Results of clinical studies of KRKA’s olanzapine in the treatment of schizophrenia and bipolar disorder Review article
Article Sidebar
Published:
Dec 31, 2014
Keywords:
generic medication, clinical trial, olanzapine, schizophrenia, bipolar disorder
Main Article Content
Abstract
Generic counterparts of brand second generation antipsychotics are widely used in Poland in the treatment of schizophrenia and bipolar disorder, although clinical efficacy of most of them wasn’t established in clinical trials. The paper presents results of open-label post-authorization clinical trials of KRKA’s olanzapine that proved clinical effects of this medication in people with schizophrenia and bipolar disorder.
Article Details
How to Cite
Murawiec , S. (2014). Results of clinical studies of KRKA’s olanzapine in the treatment of schizophrenia and bipolar disorder. Medycyna Faktow (J EBM), 7(4(25), 78-80. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2342
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Dunne S., Shannon B., Dunne C. et al.: A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol. Toxicol. 2013; 14: 1.
2. Oluboka O., Stewart S., Landry S. et al.: Does therapeutic equivalence follow bioequivalence? A randomized trial to asses clinical effects after switching from Clozaril to generic clozapine (gen-clozapine). J. Clin. Pharmacol. 2010; 50: 531-535.
3. Bevec M., Dular M.T.: Review of clinical studies with Krka’s antipsychotics in the treatment of schizophrenia and bipolar disorder. Krka Med. Farm. 2014; 26(38): 120-130.
2. Oluboka O., Stewart S., Landry S. et al.: Does therapeutic equivalence follow bioequivalence? A randomized trial to asses clinical effects after switching from Clozaril to generic clozapine (gen-clozapine). J. Clin. Pharmacol. 2010; 50: 531-535.
3. Bevec M., Dular M.T.: Review of clinical studies with Krka’s antipsychotics in the treatment of schizophrenia and bipolar disorder. Krka Med. Farm. 2014; 26(38): 120-130.